1. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. (7th January 2021) Authors: Weiss, Lan; Jung, Kwang-Mook; Nalbandian, Angele; Llewellyn, Katrina; Yu, Howard; Ta, Lac; Chang, Isabela; Migliore, Marco; Squire, Erica; Ahmed, Faizy; Piomelli, Daniele; Kimonis, Virginia Journal: Human molecular genetics Issue: Volume 29:Number 24(2020) Page Start: 3945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗